Medicare Enrolled

Dr. Cailin Jarrell, FNP-BC, PMHNP-BC

Nurse Practitioner - Family · Vancouver, WA
Low-engagement
12503 SE MILL PLAIN BLVD STE 123, Vancouver, WA 98684
3603349942
In practice since 2018 (8 years)
NPI: 1407358450 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jarrell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jarrell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jarrell

Dr. Cailin Jarrell is a nurse practitioner - family in Vancouver, WA, with 8 years of NPI registration.

Between the years covered by Open Payments, Dr. Jarrell received a total of $3,000 from 19 pharmaceutical and/or device companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jarrell is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice $3,000 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$3,000
Total received (2021-2024)
Avg $1,000/year across 3 years
Top 6% in WA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
167
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,000 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,924
2023
$1,062
2021
$14

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$324
Supernus Pharmaceuticals, Inc.
$191
Bausch Health US, LLC
$178
Neurocrine Biosciences, Inc.
$150
Janssen Pharmaceuticals, Inc
$140
Takeda Pharmaceuticals U.S.A., Inc.
$138
Lundbeck LLC
$110
Corium, LLC
$106
Alkermes, Inc.
$102
Vanda Pharmaceuticals Inc.
$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$97
Teva Pharmaceuticals USA, Inc.
$75
E.R. Squibb & Sons, L.L.C.
$69
Noven Therapeutics, LLC
$65
IRONSHORE PHARMACEUTICALS INC.
$36
Axsome Therapeutics, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$19
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$523
Corium, LLC
$408
Bausch Health US, LLC
$260
Teva Pharmaceuticals USA, Inc.
$250
Takeda Pharmaceuticals U.S.A., Inc.
$204
Janssen Pharmaceuticals, Inc
$198
Supernus Pharmaceuticals, Inc.
$191
Lundbeck LLC
$177
Neurocrine Biosciences, Inc.
$163
Alkermes, Inc.
$119
Vanda Pharmaceuticals Inc.
$100
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$97
Axsome Therapeutics, Inc.
$71
E.R. Squibb & Sons, L.L.C.
$69
Noven Therapeutics, LLC
$65
Otsuka America Pharmaceutical, Inc.
$39
IRONSHORE PHARMACEUTICALS INC.
$36
Ironshore Pharmaceuticals Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$14
Top 3 companies account for 39.7% of all-time payments
Associated products mentioned in payments ›
APLENZIN · ARISTADA · AZSTARYS · Austedo XR · Auvelity · Azstarys · CAPLYTA · COBENFY · FANAPT · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Kyleena · LYBALVI · Qelbree · REXULTI · SPRAVATO · TRINTELLIX · UZEDY · VRAYLAR · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for nurse practitioner - family in WA.

Looking for a nurse practitioner - family in Vancouver?
Compare family nurse practitioners in the Vancouver area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
915
Per 100K population
179.2
County median income
$94,948
Nearest hospital
PEACEHEALTH SOUTHWEST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jarrell is a nurse practitioner - family, with low-engagement industry engagement in the top 6% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Jarrell receive payments from pharmaceutical companies?
Yes. Dr. Jarrell received a total of $3,000 from 19 companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Jarrell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →